Economic Costs of Endocrine-Disrupting Chemical Exposure in the European Union (IMAGE)

The Endocrine Society

Economic Costs of Endocrine-Disrupting Chemical Exposure in the European Union

Caption

A new economic analysis found exposure to endocrine-disrupting chemicals likely costs the European Union €157 billion ($209 billion) a year in actual health care expenses and lost earning potential, according to a new series of studies published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism.

Credit

NYU Langone Medical Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.